Targeted gene deletion in Candida parapsilosis demonstrates the role of secreted lipase in virulence

Journal of Clinical Investigation

Volumn 117, Issue 10, 2007, Pages 3049-3058

  Gácser, Attila ^a   Trofa, David ^a   Schäfer, Wilhelm ^b   Nosanchuk, Joshua D ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF HAMBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

NOURSEOTHRICIN; TRIACYLGLYCEROL LIPASE;

ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CANDIDA PARAPSILOSIS; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SYNTHESIS; GENE; GENE DELETION; GENE LOCUS; GENE TARGETING; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BIOFILMS; CANDIDA; CANDIDIASIS; CELLS, CULTURED; FUNGAL PROTEINS; GENE DELETION; GENE TARGETING; HUMANS; LIPASE; MICE; MOUTH MUCOSA; PHAGOCYTOSIS; VIRULENCE;

EID: 34948900448     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI32294     Document Type: Article

References (41)

1. Fridkin, S.K., Kaufman, D., Edwards, J.R., Shetty, S., and Horan, T. 2006. Changing incidence of Candida bloodstream infections among NICU patients in the United States:1995-2004. Pediatrics. 117:1680- 1687.
2. Krcmery, V., et al. 2000. Fungemia in neonates: report of 80 cases from seven University hospitals. Pediatrics. 105:913-914.
3. Pagano, L., et al. 1999. Retrospective study of candidemia in patients with hematological malignancies. Clinical features, risk factors and outcome of 76 episodes. Eur. J. Haematol. 63:77-85.
4. Pfaller, M.A., et al. 1998. International surveillance of bloodstream infections due to Candida species: frequency of occurrence and antifungal susceptibilities of isolates collected in 1997 in the United States, Canada, and South America for the SENTRY Program. The SENTRY Participant Group. J. Clin. Microbiol. 36:1886-1889.
5. Pfaller, M.A., et al. 2001. International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program. J. Clin. Microbiol. 39:3254-3259.
6. Benjamin, D.K., Jr., Garges, H., and Steinbach, W.J. 2003. Candida bloodstream infection in neonates. Semin. Perinatol. 27:375-383.
7. Clerihew, L., Lamagni, T.L., Brocklehurst, P., and McGuire, W. 2007. Candida parapsilosis infection in very low birthweight infants. Arch. Dis. Child. Fetal Neonatal Ed. 92:F127-F129.
8. Bramono, K., Yamazaki, M., Tsuboi, R., and Ogawa, H. 2006. Comparison of proteinase, lipase and alpha-glucosidase activities from the clinical isolates of Candida species. Jpn. J. Infect. Dis. 59:73-76.
9. Hube, B., et al. 2000. Secreted lipases of Candida albicans: cloning, characterisation and expression analysis of a new gene family with at least ten members. Arch. Microbiol. 174:362-374.
10. Monod, M., and Borg-von, Z.M. 2002. Secreted aspartic proteases as virulence factors of Candida species. Biol. Chem. 383:1087-1093.
11. Stehr, F., et al. 2004. Expression analysis of the Candida albicans lipase gene family during experimental infections and in patient samples. FEMS Yeast Res. 4:401-408.
12. Schaller, M., Borelli, C., Korting, H.C., and Hube, B. 2005. Hydrolytic enzymes as virulence factors of Candida albicans. Mycoses. 48:365-377.
13. Neugnot, V., Moulin, G., Dubreucq, E., and Bigey, F. 2002. The lipase/acyltransferase from Candida parapsilosis: molecular cloning and characterization of purified recombinant enzymes. Eur. J. Biochem. 269:1734-1745.
14. Brunel, L., et al. 2004. High-level expression of Candida parapsilosis lipase/acyltransferase in Pichia pastoris. J. Biotechnol. 111:41-50.
15. Gacser, A., Schaefer, W., Nosanchuk, J.S., Salomon, S., and Nosanchuk, J.D. 2007. Virulence of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis in reconstituted human tissue models. Fungal Genet. Biol. In press.
16. Reuss, O., Vik, A., Kolter, R., and Morschhauser, J. 2004. The SAT1 flipper, an optimized tool for gene disruption in Candida albicans. Gene. 341:119-127.
17. Kuhn, D.M., Chandra, J., Mukherjee, P.K., and Ghannoum, M.A. 2002. Comparison of biofilms formed by Candida albicans and Candida parapsilosis on bioprosthetic surfaces. Infect. Immun. 70:878-888.
18. Filler, S.G., Swerdloff, J.N., Hobbs, C., and Luckett, P.M. 1995. Penetration and damage of endothelial cells by Candida albicans. Infect. Immun. 63:976-983.
19. Brito, L.R., et al. 2006. Clinical and microbiological aspects of candidemia due to Candida parapsilosis in Brazilian tertiary care hospitals. Med. Mycol. 44:261-266.
20. Rodero, L., et al. 2005. Multicenter study of fungemia due to yeasts in Argentina [In Spanish]. Rev. Argent. Microbiol. 37:189-195.
21. Weems, J.J., Jr. 1992. Candida parapsilosis: epidemiology, pathogenicity, clinical manifestations, and antimicrobial susceptibility. Clin. Infect. Dis. 14:756-766.
22. Fundyga, R.E., Kuykendall, R.J., Lee-Yang, W., and Lott, T.J. 2004. Evidence for aneuploidy and recombination in the human commensal yeast Candida parapsilosis. Infect. Genet. Evol. 4:37-43.
23. Nosek, J., et al. 2002. Genetic manipulation of the pathogenic yeast Candida parapsilosis. Curr. Genet. 42:27-35.
24. Gacser, A., Salomon, S., and Schafer, W. 2005. Direct transformation of a clinical isolate of Candida parapsilosis using a dominant selection marker. FEMS Microbiol. Lett. 245:117-121.
25. Hube, B., and Naglik, J. 2001. Candida albicans proteinases: resolving the mystery of a gene family. Microbiology. 147:1997-2005.
26. Jaeger, K.E., et al. 1994. Bacterial lipases. FEMS Microbiol. Rev. 15:29-63.
27. Saiman, L., et al. 2000. Risk factors for candidemia in Neonatal Intensive Care Unit patients. The National Epidemiology of Mycosis Survey study group. Pediatr. Infect. Dis. J. 19:319-324.
28. Wanten, G.J., et al. 2002. Parenteral administration of medium- but not long-chain lipid emulsions may increase the risk for infections by Candida albicans. Infect. Immun. 70:6471-6474.
29. Kouker, G., and Jaeger, K.E. 1987. Specific and sensitive plate assay for bacterial lipases. Appl. Environ. Microbiol. 53:211-213.
30. Donlan, R.M. 2001. Biofilm formation: a clinically relevant microbiological process. Clin. Infect. Dis. 33:1387-1392.
31. Douglas, L.J. 2003. Candida biofilms and their role in infection. Trends Microbiol. 11:30-36.
32. Song, J.W., et al. 2005. Differences in biofilm production by three genotypes of Candida parapsilosis from clinical sources. Med. Mycol. 43:657-661.
33. Lorenz, M.C., and Fink, G.R. 2002. Life and death in a macrophage: role of the glyoxylate cycle in virulence. Eukaryot. Cell. 1:657-662.
34. Crowe, J.D., et al. 2003. Candida albicans binds human plasminogen: identification of eight plasminogen-binding proteins. Mol. Microbiol. 47:1637-1651.
35. Sambrook, J., Fritsch, E.F., and Maniatis, T. 1989. Molecular cloning: a laboratory manual. 2nd edition. Cold Spring Harbor Laboratory Press. Cold Spring Harbor, New York, USA. 1659 pp.
36. Voigt, C.A., Schafer, W., and Salomon, S. 2005. A secreted lipase of Fusarium graminearum is a virulence factor required for infection of cereals. Plant J. 42:364-375.
37. Ran, Y., Yoshiike, T., and Ogawa, H. 1993. Lipase of Malassezia furfur: some properties and their relationship to cell growth. J. Med. Vet. Mycol. 31:77-85.
38. Martinez, L.R., and Casadevall, A. 2006. Susceptibility of Cryptococcus neoformans biofilms to antifungal agents in vitro. Antimicrob. Agents Chemother. 50:1021-1033.
39. Takao, S., et al. 1996. Role of reactive oxygen metabolites in murine peritoneal macrophage phagocytosis and phagocytic killing. Am. J. Physiol. 271:C1278-C1284.
40. Owaki, T., et al. 2000. Endothelial cells potentiate phagocytic killing by macrophages via platelet-activating factor release. Am. J. Physiol. Heart Circ. Physiol. 278:H269-H276.
41. Pruzanski, W., and Saito, S. 1988. Comparative study of phagocytosis and intracellular bactericidal activity of human monocytes and polymorphonuclear cells. Application of fluorochrome and extracellular quenching technique. Inflammation. 12:87-97.